Dopamine D2 receptor dimers in human and rat brain

被引:108
作者
Zawarynski, P
Tallerico, T
Seeman, P
Lee, SP
O'Dowd, BF
George, SR
机构
[1] Univ Toronto, Dept Pharmacol, Toronto, ON M5S 1A8, Canada
[2] Univ Toronto, Dept Psychiat, Toronto, ON M5S 1A8, Canada
[3] Univ Toronto, Dept Med, Toronto, ON M5S 1A8, Canada
[4] Ctr Addict & Mental Hlth, Toronto, ON M5S 2S1, Canada
基金
英国医学研究理事会;
关键词
dopamine receptor; photoaffinity labelling; receptor dimer;
D O I
10.1016/S0014-5793(98)01588-9
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In order to determine whether dimers of dopamine D2 receptors can occur in mammalian brain, rat and human brain striatal membranes were photolabelled with two radioactive photoaffinity compounds selective for dopamine D2 receptors, [I-125]azidophenethylspiperone and [I-125]-4-azido-5-iodonemonapride, It was found that [I-125]azidophenethylspiperone only labelled the D2 monomer, while [I-125]-4-azido-5-iodonemonapride labelled both D2 monomers and dimers, despite the fact that very high concentrations (6 nM) of both radiocompounds mere used. In addition, human cloned D2 receptors were probed with a D2-specific antibody, revealing multiple bands indicating the existence of trimers, tetramers and pentamers of D2 receptors, The different D2-binding patterns of the spiperone and Benzamide congeners may explain the different densities of dopamine D2 receptors found with these two radioligands in human brain positron tomography in health and disease. (C) 1998 Federation of European Biochemical Societies.
引用
收藏
页码:383 / 386
页数:4
相关论文
共 24 条
[1]  
AMLAIKY N, 1985, J BIOL CHEM, V260, P1983
[2]   Cardiac muscarinic receptors. Cooperativity as the basis for multiple states of affinity [J].
Chidiac, P ;
Green, MA ;
Pawagi, AB ;
Wells, JW .
BIOCHEMISTRY, 1997, 36 (24) :7361-7379
[3]  
Cvejic S, 1996, J BIOL CHEM, V271, P4073
[4]   VARIABILITY IN D-2-DOPAMINE RECEPTOR DENSITY AND AFFINITY - A PET STUDY WITH [C-11] RACLOPRIDE IN MAN [J].
FARDE, L ;
HALL, H ;
PAULI, S ;
HALLDIN, C .
SYNAPSE, 1995, 20 (03) :200-208
[5]  
FARDE L, 1990, ARCH GEN PSYCHIAT, V47, P213
[6]   A peptide derived from a beta(2)-adrenergic receptor transmembrane domain inhibits both receptor dimerization and activation [J].
Hebert, TE ;
Moffett, S ;
Morello, JP ;
Loisel, TP ;
Bichet, DG ;
Barret, C ;
Bouvier, M .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (27) :16384-16392
[7]   SYNTHESIS AND NEUROLEPTIC ACTIVITY OF BENZAMIDES - CIS-N-(1-BENZYL-2-METHYLPYRROLIDIN-3-YL)-5-CHLORO-2-METHOXY-4-(METHYLAMINO)BENZAMIDE AND RELATED-COMPOUNDS [J].
IWANAMI, S ;
TAKASHIMA, M ;
HIRATA, Y ;
HASEGAWA, O ;
USUDA, S .
JOURNAL OF MEDICINAL CHEMISTRY, 1981, 24 (10) :1224-1230
[8]  
JARVIE KR, 1988, MOL PHARMACOL, V34, P91
[9]  
LEVEY AI, 1993, P NATL ACAD SCI USA, V90, P3103
[10]   COEXPRESSION STUDIES WITH MUTANT MUSCARINIC ADRENERGIC-RECEPTORS PROVIDE EVIDENCE FOR INTERMOLECULAR CROSS-TALK BETWEEN G-PROTEIN-LINKED RECEPTORS [J].
MAGGIO, R ;
VOGEL, Z ;
WESS, J .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (07) :3103-3107